Status:
NOT_YET_RECRUITING
A Study About Association Between Microbiome, Metabolome and Clinical Characteristics in COPD Patients
Lead Sponsor:
Asan Medical Center
Collaborating Sponsors:
Seoul National University College of Medicine
HEM Pharma Inc.
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
Brief Summary
The goal of this observational registry study is to compare characteristics of gut and sputum microbiome and metabolome among COPD patients with significant smoking history, COPD patients without sign...
Eligibility Criteria
Inclusion
- COPD Patients, defined by FEV1/FVC \<0.7, who
- agree with informed consent
- have no history of acute exacerbation within 3 months
- Healthy smoker without airflow limitation, defined by FEV1/FVC ≥0.7, who
- have smoking history with at least 30 pack-year
- agree with informed consent
- do not use medication for chronic respiratory disease
Exclusion
- Withdrawal of informed consent
- History of acute exacerbation or antibiotics use within 3 months
- Difficulty to collect adequate stool, sputum and blood samples
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06101459
Start Date
December 1 2023
End Date
December 31 2028
Last Update
October 26 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.